Acetaminophen Toxicity Headed To NDAC, New FDA Drug Safety Group
This article was originally published in The Tan Sheet
Executive Summary
Potential liver toxicity risks from acetaminophen use are likely to be among the topics at the inaugural meeting of FDA's Drug Safety & Risk Management Subcommittee